Thinking of taking a trip overseas? For those who suffer from complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD), this can be a painful proposition. Extended travel is particularly difficult for those dealing with chronic pain, given the shrinking legroom and lack of flexibility airline seats…
Medical marijuana has been approved for use in 23 states, and the law in Illinois allows patients with one of 40 specified medical conditions, including complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD), to get a doctor’s recommendation to buy marijuana from one of the state’s…
Chronic pain has been the subject of several recent sources of information, such as the proposed opioid guidelines released recently by the Centers for Disease Control and Prevention (CDC), and an article published in the November 26th edition New England Journal of Medicine stating that…
Articles surrounding complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD) often describe the disorder as “painful,” “misunderstood,” and “difficult to treat” for one very important reason: like fibromyalgia, low back pain, or even a simple headache, CRPS/RSD is a human condition without reliable animal models, and…
A Pittsburg-based drug development company has received U.S. Food and Drug Administration (FDA) approval for phase 3 clinical trials of a product to treat severe, persistent pain. The medication, T-121, is being developed by Thar Pharmaceuticals and is expected to enter the market by 2019.…
Although the pain suffered is extremely real to a sufferer of complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD), it can be very hard to prove, particularly in court. Some of the difficulties that CRPS/RSD sufferers may encounter if they file a personal injury claim to…